A retrospective, observational multicenter study of effectiveness of ustekinumab in patients with Crohn's disease
Latest Information Update: 05 Jul 2021
At a glance
- Drugs Ustekinumab (Primary)
- Indications Crohn's disease
- Focus Therapeutic Use
- 05 Jul 2021 New trial record
- 23 May 2021 Primary endpoint (clinical response at week 12) has been met, according to Results presented at the Digestive Disease Week 2021.
- 23 May 2021 Results presented at the Digestive Disease Week 2021